Different cancers have mutations in IDH1 and IDH2, including a fraction of acute myeloid leukemia, low-grade glioma, secondary glioblastoma, chondrosarcoma, and cholangiocarcinoma [29–32]. This evidence concerns the gene IDH2 and cancer.